Corvus Pharmaceuticals, Inc. (CRVS) financial statements (2022 and earlier)

Company profile

Business Address 863 MITTEN ROAD
BURLINGAME, CA 94010
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:69,50044,30078,000114,60090,100134,900
Cash and cash equivalents63,45816,4555,15439,19645,1065,050
Other undisclosed cash, cash equivalents, and short-term investments6,04227,84572,84675,40444,994129,850
Receivables507     
Prepaid expense280244150166  
Other current assets128406486265720772
Other undisclosed current assets897386708558414361
Total current assets:71,31245,33679,344115,58991,234136,033
Noncurrent Assets
Operating lease, right-of-use asset3,1901,6482,327
Property, plant and equipment4519061,4622,1802,6723,248
Long-term investments and receivables34,26637,225    
Long-term investments34,26637,225    
Other noncurrent assets236414513463869869
Total noncurrent assets:38,14340,1934,3022,6433,5414,117
TOTAL ASSETS:109,45585,52983,646118,23294,775140,150
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,7976,0694,3513,0724,6332,994
Accounts payable1,5653,4672,4481,9983,4541,900
Accrued liabilities386377279425607568
Employee-related liabilities1,8462,2251,624649572526
Debt  878   
Deferred rent credit   160
Deferred revenue and credits410378
Other undisclosed current liabilities5,8956,0804,9963,7953,9262,572
Total current liabilities:9,69212,14910,2257,0278,9695,944
Noncurrent Liabilities
Long-term debt and lease obligation2,6011,2322,310   
Operating lease, liability2,6011,2322,310
Liabilities, other than long-term debt   8699711,405
Other liabilities   8699711,405
Other undisclosed noncurrent liabilities(2,601)(1,232)    
Total noncurrent liabilities:2,6011,2322,3108699711,405
Total liabilities:12,29313,38112,5357,8969,9407,349
Stockholders' equity
Stockholders' equity attributable to parent97,16272,14871,111110,33684,835132,801
Common stock533322
Additional paid in capital361,669295,281288,224280,840208,408200,709
Accumulated other comprehensive income (loss)1,869429(34)(41)(39)
Accumulated deficit(266,381)(223,140)(217,145)(170,473)(123,534)(67,871)
Total stockholders' equity:97,16272,14871,111110,33684,835132,801
TOTAL LIABILITIES AND EQUITY:109,45585,52983,646118,23294,775140,150

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Operating expenses(38,630)(43,760)(48,854)(49,222)(56,524)(36,976)
Other undisclosed operating income4,831234    
Operating loss:(38,630)(43,760)(48,854)(49,222)(56,524)(36,976)
Nonoperating income
(Investment Income, Nonoperating)
 37,459    
Loss from continuing operations before equity method investments, income taxes:(38,630)(6,301)(48,854)(49,222)(56,524)(36,976)
Other undisclosed income (loss) from continuing operations before income taxes(4,611)3062,1822,283861601
Net loss available to common stockholders, diluted:(43,241)(5,995)(46,672)(46,939)(55,663)(36,375)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(43,241)(5,995)(46,672)(46,939)(55,663)(36,375)
Comprehensive loss:(43,241)(5,995)(46,672)(46,939)(55,663)(36,375)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,865(25)637(2)6
Comprehensive loss, net of tax, attributable to parent:(41,376)(6,020)(46,609)(46,932)(55,665)(36,369)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: